Search - tctmd.com

Displaying 61 - 80 of 202

Sort: Relevancy | Date

News Conference News ESC 2020

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

L.A. McKeown

September 03, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Kenneth Kent, Angioplasty Pioneer and Original TCT Co-Director, Dies at 81

Yael L. Maxwell

May 22, 2020

News Daily News

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

Michael O'Riordan

May 19, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

COVID-19’s Lopsided Impact on Minorities Should ‘Ignite’ Reform, Experts Say

Yael L. Maxwell

April 20, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

Presentation ACC 2020

The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: COMPASS Diabetes

Presenter: Deepal L. Bhatt

March 30, 2020

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

L.A. McKeown

March 28, 2020

News Conference News ACC 2020

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

Todd Neale

March 28, 2020

News Daily News

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

Todd Neale

March 27, 2020

News Conference News

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Michael O'Riordan

March 09, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

Presentation TCT 2019

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Presenter: Sanjit Jolly

September 28, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

Presenter: Robert Welsh

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Advertisement

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Kenneth Kent, Angioplasty Pioneer and Original TCT Co-Director, Dies at 81

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

COVID-19’s Lopsided Impact on Minorities Should ‘Ignite’ Reform, Experts Say

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: COMPASS Diabetes

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content